TNF and oral mucositis: This product reduced the severity and duration of grade 3 oral mucositis, as indicated by a lower inflammatory profile (interleukin (IL)-1β, transforming growth factor (TGF)-β, and tumor necrosis factor (TNF)-α) in canine patients [27].